Immunoblotting analysis confirmed that Srx and Prxs protein expression was upregulated in CD133+ CSCs isolated from the HT29, HCT116, and SNUC5 colon cancer cell lines (Fig. 2C). This evidence concerns the gene SRXN1 and colonic neoplasm.